Ines Sifaoui Selected Research

Therapeutics

12/2023	Induction of Programmed Cell Death in Acanthamoeba culbertsoni by the Repurposed Compound Nitroxoline.
1/2023	Withaferin A-silyl ether analogs as potential anti-kinetoplastid agents targeting the programmed cell death.
12/2020	In vitro evaluation of commercial foam Belcils® on Acanthamoeba spp.
10/2020	Fluvastatin and atorvastatin induce programmed cell death in the brain eating amoeba Naegleria fowleri.
12/2017	In vitro amoebicidal and antioxidant activities of some Tunisian seaweeds.
1/2017	Programmed cell death in Acanthamoeba castellanii Neff induced by several molecules present in olive leaf extracts.
11/2014	Bioassay guided isolation and identification of anti-Acanthamoeba compounds from Tunisian olive leaf extracts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ines Sifaoui Research Topics

Disease

11	Cysts 12/2023 - 11/2014
9	Infections 06/2022 - 08/2015
8	Acanthamoeba Keratitis 11/2022 - 08/2015
7	Amebiasis (Amoebiasis) 12/2023 - 02/2014
4	Meningoencephalitis 08/2023 - 06/2022
4	Leishmaniasis 01/2023 - 06/2014
2	Neglected Diseases 08/2023 - 01/2023
1	Melanoma (Melanoma, Malignant) 10/2023
1	Neoplasms (Cancer) 10/2023
1	Disease Progression 10/2023
1	Chagas Disease (American Trypanosomiasis) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2022
1	Wounds and Injuries (Trauma) 12/2020
1	Inflammation (Inflammations) 10/2020
1	Blindness (Hysterical Blindness) 06/2018
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2018
1	Mycoses (Diseases, Fungus) 12/2017
1	Bacterial Infections (Bacterial Infection) 12/2017
1	Cachexia 12/2017
1	Glaucoma 12/2017
1	Encephalitis (Encephalitis, Rasmussen) 01/2017
1	Fever (Fevers) 08/2013
1	Malaria 08/2013

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 12/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 11/2014
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 12/2017
2	nitroxolineIBA 12/2023 - 08/2023
2	ChromatinIBA 11/2022 - 12/2017
2	pitavastatin (itavastatin)FDA Link 11/2022 - 02/2022
2	ChlorhexidineIBA 01/2022 - 02/2014
2	Ophthalmic Solutions (Eye Drops)IBA 01/2021 - 01/2018
2	Volatile Oils (Essential Oils)IBA 12/2017 - 12/2017
2	AcidsIBA 11/2014 - 10/2014
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	withaferin AIBA 08/2023
1	SteroidsIBA 08/2023
1	Therapeutic UsesIBA 01/2023
1	cerivastatin (Kazak)FDA Link 02/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2022
1	Rosuvastatin Calcium (Crestor)FDA Link 02/2022
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2022
1	polihexanideIBA 01/2022
1	Ethanol (Ethyl Alcohol)IBA 07/2021
1	SoilIBA 01/2021
1	Dexamethasone Drug Combination Tobramycin FDA LinkGeneric 01/2021
1	SolutionsIBA 12/2020
1	Fluvastatin FDA Link 10/2020
1	Atorvastatin (Lipitor)FDA Link 10/2020
1	SilverIBA 05/2020
1	Ursolic AcidIBA 08/2019
1	AntioxidantsIBA 12/2017
1	Timolol (Blocadren)FDA LinkGeneric 12/2017
1	bisabolol (levomenol)IBA 06/2017
1	maslinic acidIBA 01/2017
1	Glycogen Phosphorylase (Phosphorylase, Glycogen)IBA 01/2017
1	Caffeine (No Doz)FDA LinkGeneric 01/2017
1	hexaazatrinaphthyleneIBA 07/2016
1	oleuropeinIBA 11/2014
1	olive leaf extractIBA 06/2014
1	Voriconazole (Vfend)FDA LinkGeneric 02/2014

Therapy/Procedure

7	Therapeutics 12/2023 - 11/2014
6	Contact Lenses 06/2022 - 08/2015
2	Drug Therapy (Chemotherapy) 06/2022 - 08/2019
1	Ophthalmic Administration 11/2022
1	Corneal Transplantation (Keratoplasty) 06/2018
1	Traditional Medicine (Folk Remedies) 08/2013